MAIA·552641102·US·equity·Healthcare - Biotechnology-Activist
MAIA (MAIA BIOTECHNOLOGY INC) is held by 16 institutional investors as of Q1 2026. Largest holders: Alyeska Investment Group, L.P. ($3.5M), GEODE CAPITAL MANAGEMENT, LLC ($504,910), STATE STREET CORP ($194,530). Net institutional sentiment: Mixed.
See how MAIA's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer